Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

DRF-2189, a new insulin-sensitizing thiazolidinedione derivative from Dr. Reddy

June 16, 1998

GH secretatogues in development at Merck & Co.

June 16, 1998

Insulin sensitizers profiled at ADA meeting

June 16, 1998

NOX-101 protects against endothelial dysfunction in diabetic rats

June 16, 1998

Tanabe's selective SGLT inhibitor shows potential for diabetes Rx

June 16, 1998

More on Exocell's antiglycation agent EXO-226

June 15, 1998

Viagra is safe and effective in diabetic patients with ED

June 15, 1998

Proof of clinical efficacy of repaglinide presented at diabetes meeting

June 15, 1998

CP-320626, an antidiabetic agent with a novel mechanism of action

June 15, 1998

WAY-135201, a potassium channel opener for the treatment of diabetic neuropathy

June 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...